Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 320 filings
- On EDGAR
- CIK 1790340
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 21
News 8 of 47
Prospectuses and Registrations 8 of 18
- 424B5 Prospectus supplement for an offering Sep 25, 2025
- FWP Free writing prospectus Sep 25, 2025
- FWP Free writing prospectus Sep 24, 2025
- 424B5 Prospectus supplement for an offering Sep 24, 2025
- 424B3 Prospectus supplement for an offering Sep 8, 2025
- S-3 Shelf registration statement Sep 3, 2025
- S-3 Shelf registration statement Aug 13, 2025
- 424B5 Prospectus supplement for an offering Jun 23, 2025
Proxies 8 of 10
- DEFA14A Extra proxy material Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2026
- DEFA14A Extra proxy material Apr 21, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2025
- DEFA14A Extra proxy material Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEFA14A Extra proxy material May 1, 2023
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
Ownership 8 of 196
- SCHEDULE 13G Large holder reported a passive stake Jul 28, 2026
- 4 Insider reported a trade Jul 17, 2026
- 3 Insider reported their initial holding Jul 16, 2026
- 4 Insider reported a trade Jun 24, 2026
- 4 Insider reported a trade Jun 16, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
Other 8 of 28
- D Sep 9, 2025
- EFFECT Notice that a registration became effective Sep 8, 2025
- CORRESP Reply to SEC staff Sep 4, 2025
- UPLOAD Comment letter from SEC staff Sep 4, 2025
- EFFECT Notice that a registration became effective Aug 20, 2025
- CORRESP Reply to SEC staff Aug 18, 2025
- UPLOAD Comment letter from SEC staff Aug 18, 2025
- EFFECT Notice that a registration became effective Aug 19, 2022
Everything here comes from Immuneering Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.